Cullinan Therapeutics, Inc. (CGEM)

Cullinan Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	83.01	98.43	156.15	59.77	168.2
Short-Term Investments	315.97	368.63	311.14	230.69	42.01
Cash & Short-Term Investments	398.98	467.07	467.29	290.47	210.21
Cash Growth	-14.58%	-0.05%	60.88%	38.18%	113.13%
Other Receivables	6.46	-	-	-	-
Receivables	6.46	-	-	-	-
Prepaid Expenses	9.23	13.12	7.18	6.1	2.07
Total Current Assets	414.67	480.19	474.47	296.56	212.28
Property, Plant & Equipment	2.35	3.53	5.3	0.08	0.13
Long-Term Investments	204.44	-	80.88	140.4	-
Other Long-Term Assets	0.37	0.46	0.46	0.15	2.3
Total Assets	621.82	484.18	561.12	437.19	214.71
Accounts Payable	1.68	2.49	2.66	3.17	9.68
Accrued Expenses	26.23	23.29	12	7.6	4.64
Short-Term Debt	-	-	0.18	-	-
Current Portion of Leases	1.3	1.44	1.42	-	-
Current Income Taxes Payable	-	-	4.28	-	-
Other Current Liabilities	1.44	0.91	1.96	0.97	-
Total Current Liabilities	30.65	28.14	22.5	11.75	14.32
Long-Term Leases	0.85	2.15	3.59	-	-
Other Long-Term Liabilities	-	-	-	0.07	0.07
Total Liabilities	31.5	30.29	26.09	11.81	14.39
Common Stock	0.01	0	0.01	0	0
Additional Paid-In Capital	958.7	654.69	585.32	584.71	292.35
Retained Earnings	-368.24	-200.86	-47.7	-158.91	-93.34
Comprehensive Income & Other	-0.13	-0.13	-2.6	-0.84	-0
Total Common Equity	590.33	453.7	535.03	424.97	199.01
Minority Interest	-	0.19	-	0.4	1.3
Shareholders' Equity	590.33	453.9	535.03	425.37	200.31
Total Liabilities & Equity	621.82	484.18	561.12	437.19	214.71
Total Debt	2.15	3.59	5.19	-	-
Net Cash (Debt)	396.83	463.48	462.1	290.47	210.21
Net Cash Growth	-14.38%	0.30%	59.09%	38.18%	113.13%
Net Cash Per Share	7.38	11.15	9.91	6.74	10.57
Filing Date Shares Outstanding	58.51	43.07	39.33	44.61	43.52
Total Common Shares Outstanding	58.51	42.9	45.8	44.29	2.02
Working Capital	384.02	452.05	451.97	284.82	197.96
Book Value Per Share	10.09	10.58	11.68	9.59	98.36
Tangible Book Value	590.33	453.7	535.03	424.97	199.01
Tangible Book Value Per Share	10.09	10.58	11.68	9.59	98.36
Machinery	0.77	0.77	0.68	0.2	0.2
Leasehold Improvements	0.58	0.58	0.63	0.11	0.11

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q